quarta-feira, 7 de outubro de 2026
PesquisarExplore
pt.VIA.NEWS
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· February 3, 2026

Brandon Hall Group Prepared to Host 2026 HCM Excellence Conference Next Week

View original at globenewswire.com
Brandon Hall Group Prepared to Host 2026 HCM Excellence Conference Next Week West Palm Beach, FL, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Brandon Hall Group™ is prepared to host the 2026 HCM Excellence Conference next week, February 9-12, 2026, at the Hilton West Palm Beach…
Opening lines of the source · short snapshot — read the full document at the original

O que extraímos desta fonte

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Something fundamental has shifted since the conference last year - the uncertainty and ambiguity around AI and transformation is now fading, and organizations have enough clarity to move with purpose instead of hesitation

    80% confidence

  • Distinct layers of readiness have fully emerged in AI adoption, and early pioneers are now showing tangible outcomes, creating a visible roadmap others can follow

    80% confidence

  • Brandon Hall Group has empowered over 10,000,000 professionals globally through its innovative blend of research, learning, and advisory services

    80% confidence

  • 2026 is the time where everyone can level up with AI because the path forward is clearer and proven, and the real opportunity is about accelerating along the maturity curve with intent, confidence and evidence rather than discovering AI

    80% confidence

Citado nestas reportagens da Via News

O que sabemos · a inteligência por trás desta página
Ao vivo do substrato
O que estamos a ver
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
A nossa leitura dos dados ›
Sinais que acompanhamos
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Padrões que observamos ›
Onde as fontes divergem
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Sinalizamos conflitos abertamente ›
Verificado recentemente
✓ Verificado com a fonte original
4,985
factos rastreados à sua fonte — e sinalizamos os que não se confirmam.
101 entidades acompanhadas4,985 factos verificados com a fonte5,351 documentos-fonte arquivados
Consulte estes dados → isubstrate.com
Brandon Hall Group Prepared to Host 2026 HCM Excellence Conference Next Week — Source | Via News | pt.VIA.NEWS